首页> Journal of gynecologic oncology> Hormone replacement therapy in gynecological cancer survivors and BRCA mutation carriers: a MITO group survey.

Hormone replacement therapy in gynecological cancer survivors and BRCA mutation carriers: a MITO group survey.

导出 OA

翻译打印收藏纠错

第一作者： Innocenza,Palaia

第一单位： Department of Maternal and Child Health and Urological Sciences, Sapienza University of Rome, Rome, Italy.

作者： Innocenza,Palaia ^[1] ; Giuseppe,Caruso ^[2] ; Violante,Di Donato ^[1] ; Camilla,Turetta ^[1] ; Antonella,Savarese ^[3] ; Giorgia,Perniola ^[1] ; Roberta,Gallo ^[1] ; Andrea,Giannini ^[1] ; Vanda,Salutari ^[4] ; Giorgio,Bogani ^[1] ; Federica,Tomao ^[1] ; Diana,Giannarelli ^[5] ; Gabriella,Gentile ^[1] ; Angela,Musella ^[1] ; Ludovico,Muzii ^[1] ; Sandro,Pignata ^[6] ; MITO group

作者单位： Department of Maternal and Child Health and Urological Sciences, Sapienza University of Rome, Rome, Italy. ^[1] Department of Maternal and Child Health and Urological Sciences, Sapienza University of Rome, Rome, Italy. g.caruso@uniroma1.it. ^[2] Department of Oncology, Regina Elena National Cancer Institute, Rome, Italy. ^[3] Division of Gynecologic Oncology, Department of Women and Child Health, Fondazione Policlinico Universitario A. Gemelli IRCCS, Università Cattolica, Rome, Italy. ^[4] Biostatistic Unit, Regina Elena National Cancer Institute, Rome, Italy. ^[5] Department of Urology and Gynecology, Istituto Nazionale Tumori IRCCS Fondazione G. Pascale, Naples, Italy. ^[6]

关键词 Hormone Replacement Therapy Menopause Ovarian Neoplasms Surgery Survivors Uterine Neoplasms